TY  - CHAP
M1  - Book, Section
TI  - Eosinophilic Pulmonary Syndromes
A1  - Fitzpatrick, Meghan E.
A1  - Prendergast, Niall T.
A1  - Rivera-Lebron, Belinda
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2022
T2  - Current Medical Diagnosis & Treatment 2022
AB  - Eosinophilic  pulmonary  syndromes  are  a  diverse  group  of  disorders  typically  characterized  by  eosinophilic  pulmonary  infiltrates,  dyspnea,  and  cough.  Many  patients  have  constitutional  symptoms,  including  fever.  Common  causes  include  exposure  to  medications  (nitrofurantoin,  phenytoin,  ampicillin,  acetaminophen)  or  infection  with  helminths  (eg,  Ascaris,  hookworms,  Strongyloides)  or  filariae  (eg,  Wuchereria  bancrofti,  Brugia  malayi,  tropical  pulmonary  eosinophilia).  Löffler  syndrome  refers  to  acute  eosinophilic  pulmonary  infiltrates  in  response  to  transpulmonary  passage  of  helminth  larvae.  Pulmonary  eosinophilia  can  also  be  a  feature  of  other  illnesses,  including  allergic  bronchopulmonary  mycosis,  eosinophilic  granulomatosis  with  polyangiitis,  systemic  hypereosinophilic  syndromes,  eosinophilic  granuloma  of  the  lung  (properly  referred  to  as  pulmonary  Langerhans  cell  histiocytosis),  neoplasms,  and  numerous  interstitial  lung  diseases  (eFigure  9–18).  If  an  extrinsic  cause  is  identified,  therapy  consists  of  removal  of  the  offending  medication  or  treatment  of  the  underlying  parasitic  infection.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1186012951
ER  -